Peptides derived from α-Helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection

Transplantation

Volumn 59, Issue 3, 1995, Pages 401-410

  Shirwan, Haval ^a   Leamer, Michaela ^a   Wang, Hong K ^a   Makowka, Leonard ^a   Cramer, Donald V ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; ISOANTIBODIES; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEINS; RATS; RATS, INBRED LEW; SPLEEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0028986477     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199502150-00016     Document Type: Article

References (54)

1. Shimonkevitz R, Colon SM, Kappler JW, Marrack P, Grey HM. Antigen recognition by H-2-restricted T cells. J Immunol 1984; 133: 2067.
2. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7: 601.
3. Babitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. Bind ing of immunogenic peptides to la histocompatibility molecules. Nature 1985; 317: 359.
4. Sweetser MT, Braciale VL, Braciale TJ. Claes I major histocom patibility complex-restricted T lymphocyte recognition of the influenza hemagglutinin. J Exp Med 1989; 170: 1357.
5. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kid-ney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
6. Braun MY, McCormack A, Webb G, Batchelor JR. T cells medi ating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Transplant Proc 1993; 25: 863.
7. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
8. Lechler RI, Batchelor JR. Restoration of immunogenicity to pas senger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
9. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection-an undefined conundrum. Transplantation 1993; 52: 389.
10. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993; 1: 3.
11. Liu Z, Sun YK, Xi YP, et al. Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J Immunol 1993; 150: 3180.
12. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643.
13. Wilson DB, Blyth JL, Nowell PC. Quantitative studies on the mixed lymphocyte interaction in rats. J Exp Med 1968; 128: 1157.
14. Zijlstra M, Auchincloss H Jr, Loring JM, Chase CM, Russell PS, Jaenisch R. Skin grafts rejection by beta-2 microglobulin deficient mice. J Exp Med 1992; 175: 885.
15. Fangmann J, Dalchau R, Sawyer GJ, Priestly CA, Fabre JW. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection. Transplant Proc 1993; 25: 187.
16. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
17. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell require ments for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
18. Dalchau R, Fangmann J, Fabre JW. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur J Immunol 1992; 22: 669.
19. Casanova JL, Cerottini J-C, Matthes M, et al. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med 1992; 176: 439.
20. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mecha nisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
21. + T cell-dependent anti-body-mediated graft rejection. Immunol Today 1992; 13: 434.
22. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 176: 1521.
23. + T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Transplantation 1992; 53: 918.
24. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
25. Rada C, Lorenzi R, Powis SJ, Van den Bogaerde J, Parham P, Howard JC. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
26. Mauxion F, Sobczak J, Kress M. Characterization of five distinct cDNA clones encoding for class I RT1 antigens. Immunogenet-ics 1989; 29: 397.
27. Benichou G, Takizawa PA, Ho PT, et al. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J Exp Med 1990; 172: 1341.
28. Cramer DV, Wu GD, Chapman FA, Wang HK, Cajulis E, Ma-kowka L. A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection. Transplant Proc 1992; 24: 533.
29. Yasunaga C, Cramer DV, Chapman FA, et al. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with Brequinar Sodium. Transplantation 1993; 56: 898.
30. Shirwan H, Chi DL, Makowka L, Cramer DV. Lymphocytes infiltrating rat cardiac allografts express a limited repertoire of T-cell receptor V beta genes. J Immunol 1993; 151: 5228.
31. Shirwan H, Ohanjanian M, Burcham G, Makowka L, Cramer DV. Structure and diversity of rat T cell receptor alpha-chain genes. J Immunol 1993; 150: 2295.
32. Tabaczewski P, Shirwan H, Lewis KD, Stroynowski I. Alterna tive splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood. Proc Natl Acad Sci USA 1994; 91: 1883.
33. Shirwan H, Makowka L, Cramer DV. Analysis of the T-cell receptor Vβ repertoire in rejecting rat cardiac allografts using a quantitative polymerase chain reaction. Transplant Proc 1993; 25: 2780.
34. Klempnauer J, Steiniger B, Luck R, Gunther E. Genetic control of rat heart allograft rejection: effect of different MHC and non-MHC incompatibilities. Immunogenetics 1989; 30: 81.
35. Cramer DV. Cardiac transplantation: immune mechanisms and alloantigens involved in graft rejection. Crit Rev Immunol 1987; 7: 1.
36. Matsui M, Hioe CE, Frelinger JA. Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci USA 1993; 90: 674.
37. Heath WR, Sherman LA Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur J Immunol 1991; 21: 153.
38. Eckels DD, Gorski J, Rothbard J, Lamb JR. Peptide-mediated modulation of T-cell allorecognition. Proc Natl Acad Sci USA 1988; 85: 8191.
39. Cotner T, Mellins E, Johnson AH, Pious D. Mutations affecting antigen processing impair class II restricted allorecognition. J Immunol 1991; 146: 414.
40. Rosen-Bronson S, Yu W-Y, Karr RW. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition. J Immunol 1991; 146: 4264.
41. Bluestone JA, Kaliyaperumal A, Jameson S, Miller S, Dick R II. Peptide-induced changes in class I heavy chains alter allorecognition. J Immunol 1993; 151: 3943.
42. b by alloreactive cytotoxic T lymphocytes. Nature 1989; 341: 749.
43. Patel KJ, Neuberger MS. Antigen presentation by the B cell antigen receptor is driven by the a/b sheath and occurs independently of its cytoplasmic tyrosines. Cell 1993; 74: 939.
44. Sawyer GJ, Dalchau R, Fabre JW. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant Immunol 1993; 1:77.
45. Song ES, Link R, Olson CA, McMillan M, Goodenow RS. Allospe-cifîc cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine mqjor histocompatibility complex class I molecule. Immunology 1988; 85: 1927.
46. Parham P, Clayberger C, Zorn SL, Ludwig DS, Schoolnik GK, Krensky AM. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature 1987; 325: 625.
47. Bach FH, Grillot-Courvalin C, Kuperman LJ, et al. Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev 1977; 35: 76.
48. + T cell subsets. Transplantation 1986; 41: 634.
49. Heidecke CD, Kupiec-Weglinski JW, Lear PA, et al. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. J Immunol 1984; 133: 582.
50. + helper T cells recognizing class II alloantigens. J Immunol 1990; 144: 2425.
51. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leuko cytes from cardiac allografts into host spleens. J Exp Med 1990; 171: 307.
52. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL. Induction of immunity and oral tolerance with polymorphic class II msyor histocompatibility complex antigens in the rat. Proc Natl Acad Sci USA 1992; 89: 7762.
53. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unrespon-siveness to renal allografts. Transplantation 1993; 56: 461.
54. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27.